TRIMETHOPRIM
SQUARE PHARMS PLC · TRIMETHOPRIM
Open FDA's page for this record- Application number
- ANDA220920
- Sponsor name
- SQUARE PHARMS PLC
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20261113
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- TRIMETHOPRIM
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- TRIMETHOPRIM
- Strength
- 100MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA220920
- Brand name
- TRIMETHOPRIM
- Generic name
- TRIMETHOPRIM
- Manufacturer name
- SQUARE PHARMACEUTICALS PLC.
- Product NDC
- 76483-123
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- TRIMETHOPRIM
- SPL ID
- 59825b40-6603-4279-8f73-01a52a7b6b53
- SPL set ID
- e53ccf1b-315f-4454-824e-f69769908597
- Package NDC
- 76483-123-00
- Nui
- N0000175489, N0000000191, N0000187062, N0000187061
- Pharm class epc
- Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
- Pharm class moa
- Dihydrofolate Reductase Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
- UNII
- AN164J8Y0X
